🧪 Is Your Oncology Practice Truly Ready to Manage In-House Drug Delivery?

In the evolving world of oncology, deciding between buy-and-bill vs pharmacy-fulfilled isn’t just a financial or payer-driven choice—it’s an operational decision.

Many clinics jump into administering expensive chemotherapy or specialty drugs without asking one crucial question:
👉 Is our team operationally ready to manage this from end to end?

In our latest blog, we uncover the real-world challenges that practices face when handling oncology drug delivery in-house—and the critical systems they must have in place to succeed, including:

✅ Infusion-trained staff who follow safety and USP <800> guidelines
✅ Expert billers who know oncology-specific coding, modifiers, and payer rules
✅ Smart EMRs that support drug inventory, prior auths, and reimbursement accuracy
✅ Eligibility checks that prevent unpaid claims and patient billing disasters

💡 If even one of these areas is weak, your revenue—and your patient experience—could suffer.

📈 Read the full blog to learn how operational readiness determines success in today’s oncology drug landscape.
✅ Then ask yourself: Is your clinic ready to take on the buy-and-bill challenge?

👉 [Click here to read the full blog]